Pharmaline to open
Nahr Ibrahim factory

To increase under licensed production

Pharmaline, a manufacturer of pharmaceutical products and member of Malia Group, is building a factory in Nahr Ibrahim to be completed in late 2019.

Pharmaline will inject $13 million investments in the expansion.

The total built-up area of the factory is around 3,000 square meters (m2).

The facility is expected to double Pharmaline’s production capacity, according to Carole Abi Karam, General Manager. It will include research and development and quality control labs.

The factory will create 25 jobs, with opportunities targeting professionals and highly skilled individuals.

Pharmaline produces its own portfolio of pharmaceuticals. It is licensed to manufacture a wide range of products for nine multinationals: Abbott, Merck, Exertus, Sandoz, Novartis, Pierre Fabre, GlaxoSmithKline, Phadisco, and Tri Pharma. “Demand from multinationals to produce under license triggered the expansion,” said Abi Karam.

Pharmaline pharmaceuticals are exported to the Levant, GCC, Africa, and Europe.